Farol L. Tomson

Enteropathogenic <i>Escherichia coli</i> EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier

Farol L. Tomson, V. K. Viswanathan, Kristen J. Kanack et al. · Molecular Microbiology · 2005 · 101 citations

Life Sciences, Cell Biology, Microbiology +17

One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation

Stephen E. Lincoln, Tina Hambuch, Justin M. Zook et al. · Genetics in Medicine · 2021 · 88 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

The Post-Translational Modification in Cytochrome <i>c</i> Oxidase Is Required To Establish a Functional Environment of the Catalytic Site

Tapan K. Das, Catherine Pecoraro, Farol L. Tomson et al. · Biochemistry · 1998 · 75 citations

Life Sciences, Biochemistry, Molecular Biology +16

The Entry Point of the K-Proton-Transfer Pathway in Cytochrome <i>c</i> Oxidase

Magnus Brändén, Farol L. Tomson, Robert B. Gennis et al. · Biochemistry · 2002 · 69 citations

Life Sciences, Biochemistry, Enzyme Mechanism +16

Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic<i>Escherichia coli</i>on intestinal epithelial cells

Rachna Sharma, Samuel Tesfay, Farol L. Tomson et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2005 · 69 citations

Veterinary Medicine, Immunology, Microbiology +17